Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Lucchetta, RC"'
Autor:
Vinicius Lins Ferreira, Farinasso ,CM, Rocha , AP, Viscondi , JYK, Marra , LP, Oliveira , LA, Oliveira Junior , HA, Lucchetta , RC
Publikováno v:
Jornal de Assistência Farmacêutica e Farmacoeconomia, Vol 9, Iss s. 1 (2024)
Introdução No Brasil, as recomendações de novas tecnologias dentro de uma determinada diretriz requerem a avaliação de tecnologia em saúde, que inclui a análise de impacto orçamentário (AIO). O Departamento de Informática do Sistema Ún
Externí odkaz:
https://doaj.org/article/dad04a8442ef453496e3036974efe29e
Publikováno v:
Patient Preference and Adherence, Vol Volume 10, Pp 1787-1793 (2016)
Carolina Dagli-Hernandez,1 Rosa Camila Lucchetta,1 Tales Rubens de Nadai,2 José Carlos Fernandez Galduróz,3 Patricia de Carvalho Mastroianni1 1Department of Drugs and Medications, School of Pharmaceutical Sciences of the UNESP – Univ Estadual Pau
Externí odkaz:
https://doaj.org/article/f485041339044e6caf6161b56b2d8e3a
Publikováno v:
Pharmacy Practice, Vol 17, Iss 1, p 1361 (2019)
Background: Although the management of hyperkalemia follows expert guidelines, treatment approaches are based on traditionally accepted practice standards. New drugs have been assessed such as sodium zirconium cyclosilicate and patiromer; however, th
Externí odkaz:
https://doaj.org/article/b4ee4639cb9247389aa6560a15408853
Publikováno v:
Revista de la OFIL v.32 n.1 2022
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Resumo Objetivos: Identificar estratégias para melhorar conhecimentos, atitudes e práticas (CAP) sobre medidas de prevenção e controle da COVID-19 no mundo. Métodos: Foi realizada uma revisão sistemática de evidência quantitativa e qualitativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::68641a5c26bb3bb0a33a9721541071dd
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-714X2022000100017
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-714X2022000100017
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::3fd8baaecd139b4e1bf15f3f41a0d791
Autor:
Lucchetta, RC, Riveros, BS, Pontarolo, R, Radominski, RB, Otuki, MF, Fernandez-Llimos, F, Correr, CJ
© 2017 CLINICS. The aim of this study was to evaluate efficacy and safety of amfepramone, fenproporex and mazindol as a monotherapy for the treatment of obese or overweight patients. A systematic review of primary studies was conducted, followed by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::75bcfb8b8399bcfc56e09ec5800f1790
https://hdl.handle.net/10453/125334
https://hdl.handle.net/10453/125334
Autor:
Lucchetta, RC, Riveros, BS, Pontarolo, R, Radominski, RB, Otuki, MF, Fernandez-Llimos, F, Correr, CJ
Antiobesity pharmacotherapy remains the main point of disagreement among both scientists and regulators. This is probably due to small sample sizes, high levels of heterogeneity, and low methodological quality. For many years, Brazil was one of the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::a15288d96acb73aea1d2e54537446853
https://hdl.handle.net/10453/124363
https://hdl.handle.net/10453/124363
Autor:
Lucchetta, RC, Tonin, FS, Borba, HH, Leonart, LP, Ferreira, VL, Bonetti, AF, Riveros, BS, Becker, J, Pontarolo, R, Fernandez-Llimós, F, Wiens, A
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S203-S204
Autor:
Lucchetta, RC, Riveros, BS, Rosim, MP, Holanda, P, Melo, M, Okumura, LM, Gonçalves, VF, Nita, ME
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S166-S166